| ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown … M Pavel, D O''Toole, F Costa, J Capdevila, D Gross, R Kianmanesh, ... Neuroendocrinology 103 (2), 172-185, 2016 | 985 | 2016 |
| Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 646 | 2015 |
| ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum B Niederle, UF Pape, F Costa, D Gross, F Kelestimur, U Knigge, K Öberg, ... Neuroendocrinology 103 (2), 125-138, 2016 | 505 | 2016 |
| ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas UF Pape, A Perren, B Niederle, D Gross, T Gress, F Costa, R Arnold, ... Neuroendocrinology 95 (2), 135-156, 2012 | 470 | 2012 |
| ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers D O’Toole, A Grossman, D Gross, G Delle Fave, J Barkmanova, ... Neuroendocrinology 90 (2), 194-202, 2009 | 315 | 2009 |
| ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas) UF Pape, B Niederle, F Costa, D Gross, F Kelestimur, R Kianmanesh, ... Neuroendocrinology 103 (2), 144-152, 2016 | 268 | 2016 |
| ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology-diagnosis and prognostic stratification A Perren, A Couvelard, JY Scoazec, F Costa, I Borbath, G Delle Fave, ... Neuroendocrinology 105 (3), 196-200, 2017 | 232 | 2017 |
| Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer J Baselga, JGM Segalla, H Roché, A Del Giglio, H Pinczowski, ... Journal of clinical oncology 30 (13), 1484-1491, 2012 | 208 | 2012 |
| Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach A Barbault, FP Costa, B Bottger, RF Munden, F Bomholt, N Kuster, ... Journal of Experimental & Clinical Cancer Research 28, 1-10, 2009 | 199 | 2009 |
| Cancer cell proliferation is inhibited by specific modulation frequencies JW Zimmerman, MJ Pennison, I Brezovich, N Yi, CT Yang, R Ramaker, ... British journal of cancer 106 (2), 307-313, 2012 | 189 | 2012 |
| A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. DH Ilson, A Forastiere, M Arquette, F Costa, R Heelan, Y Huang, ... Cancer Journal (Sudbury, Mass.) 6 (5), 316-323, 2000 | 181 | 2000 |
| ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation R Arnold, YJ Chen, F Costa, M Falconi, D Gross, AB Grossman, R Hyrdel, ... Neuroendocrinology 90 (2), 227-233, 2009 | 165 | 2009 |
| Vienna Consensus Conference participants. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine … M Pavel, D O’Toole, F Costa, J Capdevila, D Gross, R Kianmanesh, ... Neuroendocrinology 103 (2), 172-185, 2016 | 162 | 2016 |
| ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy-biotherapy and novel targeted agents M Pavel, JW Valle, B Eriksson, A Rinke, M Caplin, J Chen, F Costa, ... Neuroendocrinology 105 (3), 266-280, 2017 | 144 | 2017 |
| Dendritic cell–tumor cell hybrid vaccination for metastatic cancer JAM Barbuto, LFC Ensina, AR Neves, PC Bergami-Santos, KRM Leite, ... Cancer Immunology, Immunotherapy 53, 1111-1118, 2004 | 139 | 2004 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 136 | 2020 |
| Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields FP Costa, AC De Oliveira, R Meirelles, MCC Machado, T Zanesco, ... British journal of cancer 105 (5), 640-648, 2011 | 135 | 2011 |
| 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial ECS de Camargo Etchebehere, A de Oliveira Santos, B Gumz, A Vicente, ... Journal of Nuclear Medicine 55 (10), 1598-1604, 2014 | 132 | 2014 |
| ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy-chemotherapy R Garcia-Carbonero, A Rinke, JW Valle, N Fazio, M Caplin, ... Neuroendocrinology 105 (3), 281-294, 2017 | 106 | 2017 |
| Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies JW Zimmerman, H Jimenez, MJ Pennison, I Brezovich, D Morgan, ... Chinese journal of cancer 32 (11), 573, 2013 | 102 | 2013 |
